Literature DB >> 30924492

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.

Nicolas Salvadori1,2, Bo Fan3, Waralee Teeyasoontranon4, Nicole Ngo-Giang-Huong1,2,5, Siriluk Phanomcheong6, Anita Luvira7, Achara Puangsombat8, Arunrat Suwannarat9, Ussanee Srirompotong10, Chaiwat Putiyanun11, Tim R Cressey1,2,5,12, Luc Decker1,2, Woottichai Khamduang2, Linda Harrison13, Camlin Tierney13, John A Shepherd3,14, Athena P Kourtis15, Marc Bulterys15,16, George K Siberry17, Gonzague Jourdain1,2,5.   

Abstract

In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis B virus, there was no significant effect of maternal TDF use on maternal or infant bone mineral density 1 year after delivery/birth. Clinical Trials Registration. NCT01745822.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bone mineral density; growth; hepatitis B; pregnancy; tenofovir disoproxil fumarate

Mesh：

Substances：

Year:  2019        PMID： 30924492      PMCID： PMC6579954          DOI： 10.1093/cid/ciy982

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.

Authors:  I R Hwang; Y K Choi; W K Lee; J G Kim; I K Lee; S W Kim; K G Park
Journal:  Osteoporos Int       Date:  2015-09-15       Impact factor: 4.507

2.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

3.  Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study.

Authors:  U K Møller; S Við Streym; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2011-05-25       Impact factor: 4.507

4.  Postnatal development of bone mineral status during infancy.

Authors:  W W Koo; A J Bush; J Walters; S E Carlson
Journal:  J Am Coll Nutr       Date:  1998-02       Impact factor: 3.169

5.  Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Authors:  George K Siberry; Denise L Jacobson; Heidi J Kalkwarf; Julia W Wu; Linda A DiMeglio; Ram Yogev; Katherine M Knapp; Justin J Wheeler; Laurie Butler; Rohan Hazra; Tracie L Miller; George R Seage; Russell B Van Dyke; Emily Barr; Mariam Davtyan; Lynne M Mofenson; Kenneth C Rich
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

6.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Linda Harrison; Luc Decker; Woottichai Khamduang; Camlin Tierney; Nicolas Salvadori; Tim R Cressey; Wasna Sirirungsi; Jullapong Achalapong; Prapap Yuthavisuthi; Prateep Kanjanavikai; Orada P Na Ayudhaya; Thitiporn Siriwachirachai; Sinart Prommas; Prapan Sabsanong; Aram Limtrakul; Supang Varadisai; Chaiwat Putiyanun; Pornnapa Suriyachai; Prateung Liampongsabuddhi; Suraphan Sangsawang; Wanmanee Matanasarawut; Sudanee Buranabanjasatean; Pichit Puernngooluerm; Chureeratana Bowonwatanuwong; Thanyawee Puthanakit; Virat Klinbuayaem; Satawat Thongsawat; Sombat Thanprasertsuk; George K Siberry; Diane H Watts; Nahida Chakhtoura; Trudy V Murphy; Noele P Nelson; Raymond T Chung; Stanislas Pol; Nantasak Chotivanich
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

7.  The effects of pregnancy and lactation on bone mineral density.

Authors:  C More; P Bettembuk; H P Bhattoa; A Balogh
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

8.  Bone mineral content and density of the lumbar spine of infants and toddlers: influence of age, sex, race, growth, and human milk feeding.

Authors:  Heidi J Kalkwarf; Babette S Zemel; Kimberly Yolton; James E Heubi
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

9.  Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.

Authors:  M A Rodger; S R Kahn; A Cranney; A Hodsman; M J Kovacs; A M Clement; A Lazo-Langner; W M Hague
Journal:  J Thromb Haemost       Date:  2007-08       Impact factor: 5.824

10.  Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Tim R Cressey; Lei Hua; Linda Harrison; Camlin Tierney; Nicolas Salvadori; Luc Decker; Patrinee Traisathit; Wasna Sirirungsi; Woottichai Khamduang; Chureeratana Bowonwatanuwong; Thanyawee Puthanakit; George K Siberry; Diane Heather Watts; Trudy V Murphy; Jullapong Achalapong; Suchat Hongsiriwon; Virat Klinbuayaem; Satawat Thongsawat; Raymond T Chung; Stanislas Pol; Nantasak Chotivanich
Journal:  BMC Infect Dis       Date:  2016-08-09       Impact factor: 3.090
  10 in total
  3 in total

Review 1.  Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.

Authors:  Allison Ross Eckard; Stephanie E Kirk; Nancy L Hagood
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

2.  Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women.

Authors:  Rachel K Scott; Shawnika J Hull; Robin C Richards; Kristen Klemmer; Frida Salmoran; Jim C Huang
Journal:  AIDS Care       Date:  2021-04-19

3.  Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.

Authors:  Geoffroy Liegeon; Nicole Ngo-Giang-Huong; Nicolas Salvadori; Piyawan Bunpo; Ratchada Cressey; Jullapong Achalapong; Prateep Kanjanavikai; Orada Patamasingh Na Ayudhaya; Sinart Prommas; Thitiporn Siriwachirachai; Prapan Sabsanong; Jean Yves Mary; Gonzague Jourdain
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.758
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.